On other hand, in certain lines of transgenic mice expressing human PrPC the transmission of a new variant CJD showed significant barrier, as judged from long incubation times, incomplete attack rates or lack of clinical diseases, despite identity in amino acid sequences of the host PrPC and donor PrPSc [50,51]. This evidence concerns the gene PRNP and Creutzfeldt Jacob disease.